Effectiveness of the MULTIPAP Plus intervention in youngest-old patients with multimorbidity and polypharmacy aimed at improving prescribing practices in primary care: study protocol of a cluster randomized trial
del Cura-González, Isabel ; López-Rodríguez, Juan A. ; Leiva-Fernández, Francisca ; Gimeno-Feliu, Luis A. (Universidad de Zaragoza) ; Pico-Soler, Victoria
Resumen: Background: The progressive ageing of the population is leading to an increase in multimorbidity and
polypharmacy, which in turn may increase the risk of hospitalization and mortality. The enhancement of care with
information and communications technology (ICT) can facilitate the use of prescription evaluation tools and
support system for decision-making (DSS) with the potential of optimizing the healthcare delivery process.
Objective: To assess the effectiveness and cost-effectiveness of the complex intervention MULTIPAP Plus,
compared to usual care, in improving prescriptions for young-old patients (65-74 years old) with multimorbidity and
polypharmacy in primary care.
Methods/design: This is a pragmatic cluster-randomized clinical trial with a follow-up of 18 months in health
centres of the Spanish National Health System. Unit of randomization: family physician. Unit of analysis: patient.
Idioma: Inglés
DOI: 10.1186/s13063-022-06293-x
Año: 2022
Publicado en: Trials 23, 479 (2022), [13 pp.]
ISSN: 1745-6215
Factor impacto JCR: 2.5 (2022)
Categ. JCR: MEDICINE, RESEARCH & EXPERIMENTAL rank: 99 / 136 = 0.728 (2022) - Q3 - T3
Factor impacto CITESCORE: 3.6 - Medicine (Q2)
Factor impacto SCIMAGO: 0.814 - Pharmacology (medical) (Q2) - Medicine (miscellaneous) (Q2)
Financiación: info:eu-repo/grantAgreement/ES/ISCIII-FEDER/RD16-0001-0004
Financiación: info:eu-repo/grantAgreement/ES/ISCIII-FEDER/RD16-0001-0005
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI18-01303
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI18-01515
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI18-01812
Tipo y forma: Article (Published version)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)
You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
Exportado de SIDERAL (2024-03-18-15:46:08)
Visitas y descargas
polypharmacy, which in turn may increase the risk of hospitalization and mortality. The enhancement of care with
information and communications technology (ICT) can facilitate the use of prescription evaluation tools and
support system for decision-making (DSS) with the potential of optimizing the healthcare delivery process.
Objective: To assess the effectiveness and cost-effectiveness of the complex intervention MULTIPAP Plus,
compared to usual care, in improving prescriptions for young-old patients (65-74 years old) with multimorbidity and
polypharmacy in primary care.
Methods/design: This is a pragmatic cluster-randomized clinical trial with a follow-up of 18 months in health
centres of the Spanish National Health System. Unit of randomization: family physician. Unit of analysis: patient.
Idioma: Inglés
DOI: 10.1186/s13063-022-06293-x
Año: 2022
Publicado en: Trials 23, 479 (2022), [13 pp.]
ISSN: 1745-6215
Factor impacto JCR: 2.5 (2022)
Categ. JCR: MEDICINE, RESEARCH & EXPERIMENTAL rank: 99 / 136 = 0.728 (2022) - Q3 - T3
Factor impacto CITESCORE: 3.6 - Medicine (Q2)
Factor impacto SCIMAGO: 0.814 - Pharmacology (medical) (Q2) - Medicine (miscellaneous) (Q2)
Financiación: info:eu-repo/grantAgreement/ES/ISCIII-FEDER/RD16-0001-0004
Financiación: info:eu-repo/grantAgreement/ES/ISCIII-FEDER/RD16-0001-0005
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI18-01303
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI18-01515
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI18-01812
Tipo y forma: Article (Published version)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)
You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. Exportado de SIDERAL (2024-03-18-15:46:08)
Permalink:
Visitas y descargas
Este artículo se encuentra en las siguientes colecciones:
Articles
Record created 2022-11-24, last modified 2024-03-19